About Columbia University Medical Center - PIN
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Actelion
1
Nektar Therapeutics
1
Takeda
1
Clinical Trials at Columbia University Medical Center - PIN
During the past decade, Columbia University Medical Center - PIN conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on
average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study to Assess Whether Macitentan Delays Disease Progression in Children With Pulmonary Arterial Hypertension (PAH)
2017-10-24
2024-02-29
Recruiting
300
A Study of Soticlestat in Adults and Children With Rare Epilepsies
2018-07-19
2024-11-21
Active, not recruiting
156
Study to Compare Adjuvant Immunotherapy of Bempegaldesleukin Combined With Nivolumab Versus Nivolumab After Complete Resection of Melanoma in Patients at High Risk for Recurrence
2020-07-27
2022-09-22
Terminated
765
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Columbia University Medical Center - PIN"
#1 collaborator was "Bristol-Myers Squibb" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 1 trials.
Clinical Trials Conditions at Columbia University Medical Center - PIN
According to Clinical.Site data, the most researched conditions in "Columbia University Medical Center - PIN" are
"Dravet Syndrome (DS)" (1 trials), "Epilepsy" (1 trials), "Lennox-Gastaut Syndrome (LGS)" (1 trials), "Melanoma" (1 trials) and "Melanoma (Skin)" (1 trials). Many other conditions were trialed in "Columbia University Medical Center - PIN" in a lesser frequency.
Clinical Trials Intervention Types at Columbia University Medical Center - PIN
Most popular intervention types in "Columbia University Medical Center - PIN" are "Drug" (2 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bempegaldesleukin" (1 trials), "Macitentan" (1 trials), "Nivolumab" (1 trials), "Soticlestat" (1 trials) and "Standard-of-care" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Columbia University Medical Center - PIN
The vast majority of trials in "Columbia University Medical Center - PIN" are
3 trials for "All" genders.
Clinical Trials Status at Columbia University Medical Center - PIN
Currently, there are NaN active trials in "Columbia University Medical Center - PIN".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were undefined completed trials in Columbia University Medical Center - PIN,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Columbia University Medical Center - PIN, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".